NMN Returns: What the FDA Decision Means for Supplement Brands

After months of regulatory uncertainty, nicotinamide mononucleotide (NMN) is once again recognized as a viable ingredient for dietary supplements. This development is energizing the nutraceutical industry. For brands focused on longevity, cellular health, and metabolic vitality, the FDA’s clarification opens renewed opportunities for innovation and market growth.

As a trusted turnkey supplement contract manufacturer, Reliance Vitamin helps brand owners navigate evolving regulations with the science, compliance, and manufacturing expertise needed to move forward confidently source.

What Is NMN and Why It Matters

NMN (nicotinamide mononucleotide) is a derivative of Vitamin B3 and a direct precursor to NAD⁺ (nicotinamide adenine dinucleotide), a coenzyme vital for energy metabolism and cellular repair.

Research from Harvard Medical School and Washington University in St. Louis has shown that NMN supplementation helps restore NAD⁺ levels and supports:

Healthy aging and mitochondrial efficiency^†
Enhanced metabolic and vascular performance^†
Cognitive and cellular resilience^†
Defense against oxidative stress and inflammation^†

By boosting NAD⁺ production, NMN activates sirtuin enzymes (SIRT1–SIRT7), which are key regulators of DNA repair and longevity-associated pathways.^†

Understanding the FDA’s Updated Position

The FDA’s September 2025 ruling on NMN clarified the ingredient’s standing within the dietary supplement category, confirming it can be lawfully marketed when manufactured and labeled in compliance with DSHEA regulations.

According to Michael DeLorenzo, Director of Product Development at Reliance Vitamin, “This decision from the FDA serves as a reminder that science, safety, and regulation must move hand in hand. For the supplement industry, it means carefully evaluating how NMN can be positioned responsibly in future formulations.”

This regulatory clarity removes a key adoption barrier, allowing brands to confidently invest in NMN innovation, formulation, and marketing.

NAD⁺ Precursors: What They Are and How NMN Compares

Several nutrients raise NAD⁺ levels by feeding into the same biosynthetic pathway. The most common NAD⁺ precursors include:

Precursor	Description	Common Use in Supplements
Niacin (Vitamin B3)	The original NAD⁺ precursor used for decades. High doses may cause flushing.	Energy metabolism, lipid support
Nicotinamide (NAM)	Non-flushing form that helps sustain NAD⁺ but may inhibit sirtuins at high doses.	General wellness, B-vitamin complexes^†
Nicotinamide Riboside (NR)	A patented, bioavailable NAD⁺ precursor with strong clinical support.	Healthy aging, metabolic health^†
Nicotinamide Mononucleotide (NMN)	The immediate precursor to NAD⁺ that bypasses several enzymatic steps required by other B3 forms.	Longevity, energy, cellular resilience^†

Why Switch to NMN

Now that NMN is again permitted as a dietary supplement, brands and consumers may prefer it because:

Faster NAD⁺ conversion: NMN is one enzymatic step closer to NAD⁺ than NR or niacin, supporting faster uptake (Yoshino et al., Cell Metabolism, 2011).
Clinical validation: Human studies show NMN (250–500 mg/day) safely boosts NAD⁺ and supports metabolic health.^†
Market recognition: NMN is closely associated with longevity research from Harvard and Washington University, giving it credibility and consumer trust.

Why Stack NAD⁺ Precursors

Preclinical studies show synergistic effects when NMN is combined with resveratrol, pterostilbene, or CoQ10, enhancing mitochondrial function and sirtuin activation (Mills et al., Nature Aging, 2021; Gomes et al., Cell, 2013).^†

Formulating with multiple precursors such as NR, NMN, and resveratrol can:

Target complementary NAD⁺ biosynthetic pathways
Support multi-tissue NAD⁺ availability
Differentiate product positioning within the growing cellular-resilience category

Market Momentum: Why Longevity and NAD⁺ Products Are Set to Grow

The return of NMN aligns with one of the most powerful growth trends in the global wellness economy: the pursuit of longevity, vitality, and healthy aging.

Longevity and Wellness Macro Tailwinds (Through 2028–2035)
- The Global Wellness Institute reports that the global wellness economy reached $6.3 trillion in 2023 and is projected to approach $9 trillion by 2028.
- The U.S. Census Bureau projects that by 2030, one in five Americans will be aged 65 or older, driving sustained demand for healthy-aging and vitality products.
Category Growth: Anti-Aging and Healthy Aging Supplements (2025–2033)
- Anti-aging supplements: $4.47 billion (2024) → $6.99 billion (2030), a CAGR of approximately 7.9% (Grand View Research, 2024).
- Longevity and brain health supplements: $796 million (2022) → $1.35 billion (2030), a CAGR of approximately 6.8% (Grand View Research, 2024).
- The NAD⁺ booster segment is forecast to reach $2.1 billion by 2033 (Growth Market Reports, 2024).

These figures confirm that longevity and cellular-resilience supplements are among the most resilient and forward-looking categories in the nutraceutical market.

Formulation and Research Insights

Clinically Supported Dosing: 250–500 mg/day in human trials with favorable safety and efficacy.
Synergistic Ingredients: Works well with resveratrol, CoQ10, pterostilbene, and alpha-lipoic acid.
Mechanism of Action: Elevates intracellular NAD⁺, activating SIRT1, AMPK, and PARP for DNA repair and metabolic efficiency.^†
Market Outlook: The combination of demographic trends, rising wellness investment, and FDA regulatory clarity positions NMN as a high-growth innovation target through 2033.

What This Means for Brands

The reinstatement of NMN creates both opportunity and responsibility. Success depends on transparent labeling, science-based claims, and a compliant manufacturing partner.

By partnering with Reliance Vitamin, supplement brands can move swiftly and confidently into the revitalized longevity category, supported by in-house R&D, GMP-certified production, and full-service packaging.

Looking to Formulate With NMN? Let’s Build It Right

Speed matters. Reliance Vitamin offers a stock NMN product ready for fast production and packaging, helping brands respond quickly to renewed market demand and get to shelf faster than ever.

If you’re looking for something truly unique, our in-house R&D and formulation teams can also develop a custom NMN blend tailored to your brand’s goals and target audience.

Whether you want to launch quickly with our proven stock formula or build a differentiated NMN innovation from the ground up, Reliance has you covered.

^†These statements have not been evaluated by The Food and Drug Administration. This product is not intended to diagnose, treat, cure or prevent any disease.